Jamie Perse
Stock Analyst at Goldman Sachs
(2.54)
# 2,247
Out of 5,150 analysts
67
Total ratings
54.76%
Success rate
12.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Perse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Neutral | $2.5 → $5 | $0.70 | +615.82% | 7 | May 8, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $134 → $154 | $244.80 | -37.09% | 12 | May 5, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $10 | $7.33 | +36.43% | 7 | Dec 16, 2024 | |
| OPCH Option Care Health | Downgrades: Neutral | $38 → $27 | $30.72 | -12.11% | 3 | Nov 5, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $32 | $23.56 | +35.82% | 1 | Aug 19, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $21 → $18 | $41.96 | -57.10% | 3 | Aug 9, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $200 → $229 | $202.31 | +13.19% | 16 | Jul 30, 2024 | |
| INNV InnovAge Holding | Maintains: Neutral | $8 → $7 | $10.60 | -33.96% | 5 | Feb 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Neutral | n/a | $544.41 | - | 10 | Dec 11, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $13 | $13.61 | -4.48% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $24.30 | +31.69% | 1 | Feb 3, 2023 |
agilon health
May 8, 2025
Maintains: Neutral
Price Target: $2.5 → $5
Current: $0.70
Upside: +615.82%
Tenet Healthcare
May 5, 2025
Maintains: Neutral
Price Target: $134 → $154
Current: $244.80
Upside: -37.09%
LifeStance Health Group
Dec 16, 2024
Upgrades: Buy
Price Target: $10
Current: $7.33
Upside: +36.43%
Option Care Health
Nov 5, 2024
Downgrades: Neutral
Price Target: $38 → $27
Current: $30.72
Upside: -12.11%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $32
Current: $23.56
Upside: +35.82%
BrightSpring Health Services
Aug 9, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $41.96
Upside: -57.10%
Universal Health Services
Jul 30, 2024
Maintains: Buy
Price Target: $200 → $229
Current: $202.31
Upside: +13.19%
InnovAge Holding
Feb 8, 2024
Maintains: Neutral
Price Target: $8 → $7
Current: $10.60
Upside: -33.96%
HCA Healthcare
Dec 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $544.41
Upside: -
Enhabit
Jul 17, 2023
Maintains: Neutral
Price Target: $15 → $13
Current: $13.61
Upside: -4.48%
Feb 3, 2023
Initiates: Buy
Price Target: $32
Current: $24.30
Upside: +31.69%